Matches in SemOpenAlex for { <https://semopenalex.org/work/W4319877930> ?p ?o ?g. }
- W4319877930 abstract "ABSTRACT Background and objectives An unmet need exists for validated quantitative tools to measure multiple sclerosis (MS) disease activity and progression. We developed a custom immunoassay-based MS disease activity (MSDA) Test incorporating 18 protein concentrations into an algorithm to calculate four Disease Pathway scores (Immunomodulation, Neuroinflammation, Myelin Biology, and Neuroaxonal Integrity) and an overall Disease Activity score. The objective was to clinically validate the MSDA Test based on associations between scores and clinical/radiographic assessments. Methods Serum samples (N=614) from patients with MS at multiple sites were split into Train (n=426; algorithm development) and Test (n=188; evaluation) subsets. Subsets were stratified by demographics, sample counts per site, and gadolinium-positive (Gd+) lesion counts; age and sex were used to demographically adjust protein concentrations. MSDA Test results were evaluated for potential association with Gd+ lesion presence/absence, new and enlarging (N/E) T2 lesion presence, and active versus stable disease status (composite endpoint combining radiographic and clinical evidence of disease activity). Results A multi-protein model was developed (trained and cross-validated) using the Train subset. When applied to the Test subset, the model classified the Gd+ lesion presence/absence, N/E T2 lesion presence, and active versus stable disease status assessments with an area under the receiver operating characteristic (AUROC) of 0.781, 0.750, and 0.768, respectively. In each case, the multi-protein model had significantly (bootstrapped, one-sided p <0.05) greater AUROC performance when compared with the top-performing, demographically adjusted (by age and sex) single-protein model based on neurofilament light polypeptide chain. Algorithmic score thresholds corresponded to low, moderate, or high levels of disease activity. Based on the Test subset, the diagnostic odds ratios determined that the odds of having ≥1 Gd+ lesions among samples with a moderate/high Disease Activity score were 4.49 times that of a low Disease Activity score. The odds of having ≥2 Gd+ lesions among samples with a high Disease Activity score were 20.99 times that of a low/moderate Disease Activity score. Discussion The MSDA Test was clinically validated; the multi-protein model had greater performance compared with the top-performing single-protein model. The MSDA Test may serve as a quantitative and objective tool to enhance care for MS." @default.
- W4319877930 created "2023-02-11" @default.
- W4319877930 creator A5002547761 @default.
- W4319877930 creator A5013893226 @default.
- W4319877930 creator A5014372247 @default.
- W4319877930 creator A5020520433 @default.
- W4319877930 creator A5023046022 @default.
- W4319877930 creator A5027116773 @default.
- W4319877930 creator A5029459205 @default.
- W4319877930 creator A5030020707 @default.
- W4319877930 creator A5035081520 @default.
- W4319877930 creator A5040230459 @default.
- W4319877930 creator A5040295173 @default.
- W4319877930 creator A5047474551 @default.
- W4319877930 creator A5047639059 @default.
- W4319877930 creator A5055725062 @default.
- W4319877930 creator A5060630574 @default.
- W4319877930 creator A5069092257 @default.
- W4319877930 creator A5072497750 @default.
- W4319877930 creator A5084049314 @default.
- W4319877930 creator A5084489116 @default.
- W4319877930 creator A5085379143 @default.
- W4319877930 date "2023-02-10" @default.
- W4319877930 modified "2023-10-01" @default.
- W4319877930 title "Clinical Validation of a Multi-protein, Serum-based Assay for Disease Activity Assessments in Multiple Sclerosis" @default.
- W4319877930 cites W1984199327 @default.
- W4319877930 cites W1998761401 @default.
- W4319877930 cites W2001356567 @default.
- W4319877930 cites W2006617902 @default.
- W4319877930 cites W2010011361 @default.
- W4319877930 cites W2010084870 @default.
- W4319877930 cites W2079242778 @default.
- W4319877930 cites W2087589796 @default.
- W4319877930 cites W2087939913 @default.
- W4319877930 cites W2105206040 @default.
- W4319877930 cites W2105490558 @default.
- W4319877930 cites W2118698089 @default.
- W4319877930 cites W2119874037 @default.
- W4319877930 cites W2143953700 @default.
- W4319877930 cites W2144946000 @default.
- W4319877930 cites W2145185401 @default.
- W4319877930 cites W2148563799 @default.
- W4319877930 cites W2163398467 @default.
- W4319877930 cites W2469997639 @default.
- W4319877930 cites W2545839033 @default.
- W4319877930 cites W2591898001 @default.
- W4319877930 cites W2612505191 @default.
- W4319877930 cites W2614808368 @default.
- W4319877930 cites W2704729794 @default.
- W4319877930 cites W2751736380 @default.
- W4319877930 cites W2777074421 @default.
- W4319877930 cites W2784859886 @default.
- W4319877930 cites W2789822688 @default.
- W4319877930 cites W2792356388 @default.
- W4319877930 cites W2799462250 @default.
- W4319877930 cites W2806791998 @default.
- W4319877930 cites W2898127494 @default.
- W4319877930 cites W2922528121 @default.
- W4319877930 cites W2939789416 @default.
- W4319877930 cites W2967956895 @default.
- W4319877930 cites W2983212738 @default.
- W4319877930 cites W2995835837 @default.
- W4319877930 cites W3001808143 @default.
- W4319877930 cites W3026671074 @default.
- W4319877930 cites W3031154268 @default.
- W4319877930 cites W3080224581 @default.
- W4319877930 cites W3097365520 @default.
- W4319877930 cites W3111195318 @default.
- W4319877930 cites W4211254511 @default.
- W4319877930 cites W4281708646 @default.
- W4319877930 doi "https://doi.org/10.1101/2023.02.08.23285438" @default.
- W4319877930 hasPublicationYear "2023" @default.
- W4319877930 type Work @default.
- W4319877930 citedByCount "1" @default.
- W4319877930 countsByYear W43198779302023 @default.
- W4319877930 crossrefType "posted-content" @default.
- W4319877930 hasAuthorship W4319877930A5002547761 @default.
- W4319877930 hasAuthorship W4319877930A5013893226 @default.
- W4319877930 hasAuthorship W4319877930A5014372247 @default.
- W4319877930 hasAuthorship W4319877930A5020520433 @default.
- W4319877930 hasAuthorship W4319877930A5023046022 @default.
- W4319877930 hasAuthorship W4319877930A5027116773 @default.
- W4319877930 hasAuthorship W4319877930A5029459205 @default.
- W4319877930 hasAuthorship W4319877930A5030020707 @default.
- W4319877930 hasAuthorship W4319877930A5035081520 @default.
- W4319877930 hasAuthorship W4319877930A5040230459 @default.
- W4319877930 hasAuthorship W4319877930A5040295173 @default.
- W4319877930 hasAuthorship W4319877930A5047474551 @default.
- W4319877930 hasAuthorship W4319877930A5047639059 @default.
- W4319877930 hasAuthorship W4319877930A5055725062 @default.
- W4319877930 hasAuthorship W4319877930A5060630574 @default.
- W4319877930 hasAuthorship W4319877930A5069092257 @default.
- W4319877930 hasAuthorship W4319877930A5072497750 @default.
- W4319877930 hasAuthorship W4319877930A5084049314 @default.
- W4319877930 hasAuthorship W4319877930A5084489116 @default.
- W4319877930 hasAuthorship W4319877930A5085379143 @default.
- W4319877930 hasBestOaLocation W43198779301 @default.
- W4319877930 hasConcept C126322002 @default.
- W4319877930 hasConcept C126838900 @default.
- W4319877930 hasConcept C142724271 @default.